“Real‐World” Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States

OBJECTIVES: The 30‐day clinical outcomes with prasugrel or ticagrelor were compared using a US payer database in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). BACKGROUND: Prasugrel and ticagrelor demonstrated superior efficacy with increased non‐cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Larmore, Cynthia, Effron, Mark B., Molife, Cliff, DeKoven, Mitch, Zhu, Yajun, Lu, Jingsong, Karkare, Swapna, Lieu, Hsiao D., Lee, Won Chan, Vetrovec, George W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215531/
https://www.ncbi.nlm.nih.gov/pubmed/26577386
http://dx.doi.org/10.1002/ccd.26279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215531/
https://www.ncbi.nlm.nih.gov/pubmed/26577386
http://dx.doi.org/10.1002/ccd.26279

Ejemplares similares